Skip to main content
Tinavi Medical Technologies Co.,Ltd. logo

Tinavi Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688277 ISIN · CNE100004256 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 760 across all filing types
Latest filing 2025-02-27 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688277

About Tinavi Medical Technologies Co.,Ltd.

https://www.tinavi.com/

Tinavi Medical Technologies Co.,Ltd. specializes in the design, development, and commercialization of orthopedic surgical robotic systems. Its primary offering, the TiRobot system, provides a multi-functional platform for spine and trauma surgeries, supporting procedures such as pedicle screw fixation and pelvic fracture reduction. The technology incorporates high-definition 3D imaging, precise mechanical arms, and advanced navigation software to facilitate minimally invasive operations with sub-millimeter accuracy. By integrating preoperative planning with real-time intraoperative guidance, the system aims to enhance surgical precision, reduce recovery times, and minimize radiation exposure for clinical teams. The company focuses on delivering intelligent robotic solutions to hospitals and specialized surgical centers to improve the consistency and safety of complex orthopedic interventions.

Recent filings

Filing Released Lang Actions
第六届董事会第十八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Beijing Tianzhihang Medical Technology Co., Ltd. It details the convening of the 18th meeting of the 6th board, voting results on stock incentive plans, and related corporate governance matters. The content focuses on board decisions and management actions rather than financial results, audit opinions, or shareholder voting outcomes. It does not contain financial statements or earnings data, nor is it a report or presentation. The document is clearly a Board/Management Information announcement about board meeting resolutions and management decisions regarding stock incentives. Therefore, the appropriate classification is MANG (Board/Management Information). The document length and detail support a high confidence level.
2025-02-27 Chinese
2024年业绩快报
Earnings Release Classification · 95% confidence The document is titled as a "2024年度业绩快报" which translates to "2024 Annual Performance Express Report" or "Annual Earnings Quick Report." It contains preliminary financial data for the full year 2024, including revenue, profit, net profit, and asset figures. The data is explicitly stated as preliminary and unaudited, with a disclaimer that the final audited data will be in the 2024 Annual Report. The document is relatively short (1489 characters) and serves as an initial earnings announcement with key financial highlights rather than a full detailed report. This matches the definition of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks comprehensive financial statements and detailed analysis. Therefore, the correct classification is Earnings Release (ER). FY 2024
2025-02-26 Chinese
简式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details the changes in shareholding percentages of two investment funds in a listed company, Beijing Tianzhihang Medical Technology Co., Ltd., including specifics on share quantities before and after the change, the nature of the shareholding changes, and compliance with relevant securities laws. The document includes detailed disclosures about the shareholders, their shareholding percentages, and the purpose and method of the share reduction. It is a formal report on changes in major shareholdings, consistent with notifications required when significant shareholders cross ownership thresholds or reduce holdings. There is no indication that this is an announcement of a report publication, nor is it a financial report or management discussion. The content fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2025-02-18 Chinese
关于股东权益变动的提示性公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding changes in shareholder equity, specifically detailing the reduction in shareholdings by certain investment funds. It includes information about the shareholders, the number of shares reduced, and the impact on ownership percentages. The document explicitly mentions it is a "简式权益变动报告书" (Simplified Equity Change Report) and provides details about the shareholding changes without any financial statements or broader company performance data. This type of document fits the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels. The document length is short (2113 characters), and it is not an announcement of a report publication but the report itself about shareholding changes. Therefore, the correct classification is MRQ with high confidence.
2025-02-18 Chinese
关于取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Beijing Tianzhihang Medical Technology Co., Ltd. about obtaining a medical device registration certificate issued by the National Medical Products Administration. It details the certificate number, validity, product scope, and potential impact on the company. The document is short (767 characters) and serves as a regulatory announcement about a certificate acquisition rather than a financial report or detailed management discussion. It does not contain financial data, earnings, or management changes. It is not a report publication announcement since it is not about releasing a report but about a regulatory approval. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2025-02-12 Chinese
2024年度业绩预告
Regulatory Filings Classification · 95% confidence The document is a 2024 annual performance forecast (业绩预告) for Beijing Tianzhihang Medical Technology Co., Ltd. It provides preliminary estimated financial results for the full year 2024, including revenue and net profit/loss ranges, and compares them to the prior year 2023. It explicitly states that the forecast has not been audited by a registered accountant. The document is short (1172 characters) and serves as a forward-looking earnings guidance rather than a full financial report. It is not a full Annual Report (10-K) or Interim Report (IR) because it lacks actual audited financial statements or detailed financial analysis. It is also not an Earnings Release (ER) since it is a forecast, not an initial announcement of quarterly or periodical results. The document is a typical earnings forecast announcement, which falls under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories. Confidence is high given the clear nature of the document as an earnings forecast announcement.
2025-01-24 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.